Navigation Links
Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
Date:11/6/2008

> Time: 9:00 a.m. - 5:00 p.m.

Hall A-B1, Poster Board C6

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proof of concept that are engineered to provide significant advances over current treatments for cardiovascular and inflammatory diseases and cancer.

Portola's two lead Phase II compounds, betrixaban, an oral Factor Xa inhibitor and PRT060128, an ADP receptor antagonist, target the global multi- billion dollar antithrombotic market. Both product candidates have best-in- class features versus current and novel agents in development and address the hospital, specialty, and chronic care markets. The Company's earlier-stage programs are leveraging its chemistry and kinase expertise to develop specific Syk and JAK inhibitors to treat cancer and inflammatory diseases with broader activity. The company also has a novel anticoagulant antidote program with the potential to help manage the more than 20 million patients expected to be treated with anticoagulants worldwide in the next decade. For additional information, visit http://www.portola.com.


'/>"/>
SOURCE Portola Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
2. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
3. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
4. NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
5. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
6. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
7. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
8. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
9. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
10. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
11. Lutonix Inc. Announces $20 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Life Science Angels (LSA), a ... promising emerging biotech, medical device, genomics, diagnostic and ... Angel Investment Group in the U.S.  LSA was ... out of 370 angel groups analyzed nationwide based ... (connections), selection aptitude and brand recognition.  LSA was ...
(Date:9/30/2014)... Headquartered in Anaheim, California ... comprised of several specialized partners focused on leveraging the ... expertise of its team of professionals to improve the ... of more than 10 professional diagnostic tests for hospitals, ... 8 retail consumer tests is proud to announce an ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... every clinical laboratory possesses one essential devicea centrifuge. ... refrigerated or non-cooled, but this apparatus, because of ... creating spin-induced high g-forces, has long been a ... For all this utility, these machines are true ...
... (EBV), which causes infectious mononucleosis (IM), is one of ... most people become infected with EBV sometime during their ... percent of adults between 35 and 40 years of ... the U.S., infection with EBV most often occurs during ...
Cached Medicine Technology:Bench-Top Centrifuges--Basic Tools for the Small Lab 2Bench-Top Centrifuges--Basic Tools for the Small Lab 3Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
(Date:9/30/2014)... 30, 2014 Sheridan Healthcare, ... the nation, today announced that Adam Blomberg, MD, ... division, will present at the Society for Healthcare ... Connections 2014 . The conference will be held ... Connections is a four-day conference that draws in ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in the ... a loving couple facing the most monumental challenge of ... Steve was diagnosed with ALS – more commonly known ... the couple’s second wedding anniversary. Pam is now ... “Care, Support & ALS,” that’s part of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Houstonians seeking ... a place to visit on the Internet. Paul ... Houston’s most respected cosmetic surgeons, has launched a new ... the benefits of Botox Cosmetic services. The ... , According to the new website, Botox Cosmetic ...
(Date:9/30/2014)... Edward D. Buckingham, M.D., owner of the Buckingham ... be a director of a fellowship for the American ... program. The announcement came last week from the AAFPRS ... and Research Foundation for the AAFPRS fellowship program is ... postgraduate program in the world for the training of ...
(Date:9/30/2014)... TrailMyx.com —the country’s leading purveyor of ... Month: raw pumpkin seeds. , Pumpkin seeds—also known as ... protein, and valued by experts as an excellent source ... E. They are prized for their contributions to bone ... , Of course, pumpkin seeds are closely associated with ...
Breaking Medicine News(10 mins):Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 2Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 3Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:TrailMyx.com Features October Flavor of the Month 2
... which is set to appear online later in ... the possible implications for traumatic brain injury (TBI) ... anti-inflammatory drugs (NSAIDS) as ibuprofen for chronic pain. ... humans have shown that long-term use of ibuprofen ...
... Children's Research Hospital it was found that a gene responsible ... also initiate leukemias. // ,This gene results in leukemia ... The discovery of the normal function of this gene suggests ... form might be used in leukemia patients with few serious ...
... certain genetic variation, along with inflammatory factors and smoking, ... macular degeneration, according to a study.// ,Age-related macular ... visual loss in the elderly of the Western world, ... play a role in AMD, and inflammation also may ...
... British schools are concerned that children in primary schools ... schools to tackle inappropriate// sexual behaviour. ,Children ... other in a rather "sexualised" manner with games such ... enough not to set alarm bells ringing. ...
... relied on humid air to relieve the barking cough and ... sends worried families to the emergency room. Now a new ... little medical benefit. ,“Typically you get people to ... you get them to boil a kettle in the room, ...
... that the elderly should not be barred from stroke rehabilitation ... the older a stroke victim, the less are the chances ... people over 80 years of age can recover as much ... the researchers studied 878 stroke survivors who received rehabilitation in ...
Cached Medicine News:Health News:Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 3Health News:Genetic Variation Linked to Age-Related Macular Degeneration 2Health News:Humid Air is Little Help for Croup's Barking Cough 2Health News:Humid Air is Little Help for Croup's Barking Cough 3